Dyne Therapeutics To Present Preclinical Data On Four Candidates For Exon 53, 45, 44, And 55 Skipping In DMD At NMSG Meeting September 25; All Advancing Into IND-Enabling Studies

Loading news article.

Dyne Therapeutics To Present Preclinical Data On Four Candidates For Exon 53, 45, 44, And 55 Skipping In DMD At NMSG Meeting September 25; All Advancing Into IND-Enabling Studies | WAPE

Dyne Therapeutics To Present Preclinical Data On Four Candidates For Exon 53, 45, 44, And 55 Skipping In DMD At NMSG Meeting September 25; All Advancing Into IND-Enabling Studies

Article summary

Related companies

Comments —